Michael E. Steffey - Concepedia

Concepedia

Author

Michael E. Steffey

University of Michigan

Also Known As

M E Steffey, M.E. Steffey, Michael E. Steffey

33

Publications

1.2K

Citations

15

H-Index

26

Concepts

All Affiliations

University of Michigan Abbott Fund

ME

About

Michael E. Steffey is an author at University of Michigan specializing in medicine, drug discovery, and signal transduction.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	233
2	Natural Sciences	3	3	87
3	Biochemistry	3	3	87
4	Biomolecular Engineering	1	1	44
5	Cell Biology	1	1	125

Michael E. Steffey

×

14

Publications

1.2K

Citations

14

H-Index

	Year	Citations
Calcimimetics with potent and selective activity on the parathyroid calcium receptor Edward F. Nemeth, Michael E. Steffey, Lance G. Hammerland, Proceedings of the National Academy of Sciences	1998	611
Development of a Highly Selective c-Src Kinase Inhibitor Kristoffer Brandvold, Michael E. Steffey, Christel C. Fox, ACS Chemical Biology Cancer BiologyTumor BiologyReceptor Tyrosine KinaseAnti-cancer AgentCell Signaling	2012	125
Serine mutations in transmembrane V of the dopamine D1 receptor affect ligand interactions and receptor activation. Nancy J. Pollock, Arlene M. Manelli, C. Hutchins, Journal of Biological Chemistry	1992	102
Cell Surface Expression of the Melanocortin-4 Receptor Is Dependent on a C-terminal Di-isoleucine Sequence at Codons 316/317 Donald VanLeeuwen, Michael E. Steffey, Christopher J. Donahue, Journal of Biological Chemistry	2003	53
Development of a Chimeric c-Src Kinase and HDAC Inhibitor Kristin S. Ko, Michael E. Steffey, Kristoffer Brandvold, ACS Medicinal Chemistry Letters	2013	46
Irreversible Inhibitors of c-Src Kinase That Target a Nonconserved Cysteine Frank E. Kwarcinski, Christel C. Fox, Michael E. Steffey, ACS Chemical Biology Drug TargetInhibitor SelectivityInhibitor ScaffoldsMolecular BiologyNonconserved Cysteine	2012	44
Cloning and characterization of a truncated dopamine D1 receptor from goldfish retina: stimulation of cyclic AMP production and calcium mobilization. D E Frail, Arlene M. Manelli, David G. Witte, Molecular Pharmacology	1993	43
Type-A cholecystokinin binding sites in cow brain: characterization using (-)-[3H]L364718 membrane binding assays. Ronald W. Barrett, Michael E. Steffey, C A Wolfram Molecular Pharmacology	1989	31
Exquisitely Specific Bisubstrate Inhibitors of c-Src Kinase Kristoffer Brandvold, Shana Marie Santos, Meghan E. Breen, ACS Chemical Biology Drug TargetC-src SignalingSelective Bisubstrate InhibitorChemical BiologyMolecular Pharmacology	2015	27
UM-164: A Potent c-Src/p38 Kinase Inhibitor with <i>In Vivo</i> Activity against Triple-Negative Breast Cancer Rabia A. Gilani, Sameer Phadke, Li Bao, Clinical Cancer Research	2016	27

Page 1